Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment trial

INTRODUCTION: The Strategic Timing of AntiRetroviral Treatment (START) trial has recruited antiretroviral-naïve individuals with high CD4 cell counts from all world regions. We describe the distribution of cardiovascular (CVD) risk factors, overall and by geographic region, at study baseline. METHOD...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:HIV Med
Huvudupphovsmän: Soliman, Elsayed Z., Sharma, Shweta, Arastéh, Keikawus, Wohl, David, Achhra, Amit, Tambussi, Giuseppe, O’Connor, Jemma, Stein, James H., Duprez, Daniel A., Neaton, James D., Phillips, Andrew
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4341949/
https://ncbi.nlm.nih.gov/pubmed/25711323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12233
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk